New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Stanford Health Care – Now
Driving Development of CAR-T and Other New Cancer Treatments
CAR-T therapy is the revolutionary new cancer treatment option that can help people avoid chemotherapy and radiation therapy.
The Blood and Marrow Transplant Program in the Stanford Cancer Institute— a National Cancer Institute Comprehensive Cancer Center—is the only site in Northern California that offers this option, which is called an “immunotherapy” because it is driven by the power of each person’s own immune system.
Our physicians led the clinical trials that helped bring CAR-T therapy to FDA approval. The FDA fast-tracked approval for patients with certain types of lymphoma and acute leukemia who did not benefit from chemotherapy, radiation therapy, or stem cell treatment.
Here’s how the procedure works: Stanford Health Care specialists remove T-cells from the patient’s blood. In the lab, the cells are reengineered with a virus that will recognize and bind to cancer cells. The blood is then reinfused back into the patient, where CARs (which stands for chimeric antigen receptors) multiply and attack tumor cells.
Now that CAR-T is in use for blood cancers, we are studying the therapy’s value in other types of cancer, such as breast, brain, and lung. Ultimately, the goal is to use CAR-T wherever effective rather than subject patients to the toxicity and other issues associated with chemotherapy.
UNIQUELY STANFORD: FORWARD-THINKING INNOVATION-MINDED
We combine academia, scientific exploration, and health care delivery into a singularly strong entity with unlimited potential to change health care for good. It's part of our DNA—fundamental to who we are as one of the world's leading academic medical centers.